Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients-Reference-Cited by-同舟云学术

Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients

Published:2016 Issue:1 Volume:57 Page:30-34
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Koike Hideki¹,Fujino Tadashi¹,Koike Makiko¹,Shinohara Masaya¹,Kitahara Ken¹,Kinoshita Toshio¹,Yuzawa Hitomi¹,Suzuki Takeya¹,Sato Hideyuki¹,Fukunaga Shunji¹,Kobayashi Kenzaburo¹,Ikeda Takanori¹

Affiliation:

1. Department of Cardiovascular Medicine, Toho University Faculty of Medicine

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/57/1/57_15-276/_pdf

Reference27 articles.

1. 1. Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003; 41: 255-62.

2. 2. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990; 82: 51-9.

3. 3. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998; 98: 2574-9.